RMD vs STRO · P/E 29, $37.68B cap vs rev $62.0M
ResMed Inc (RMD) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
RMD does not have a complete income-statement cache yet.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the RMD and STRO stock pages for the full models.
Not investment advice.